Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


FORM 8-K

 


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 11, 2007

 


Celsion Corporation

(Exact Name of Registrant as Specified in Charter)

 


 

Delaware   000-14242   52-1256615

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

10220-L Old Columbia Road, Columbia, Maryland   21046-2364
(Address of principal executive office)   (Zip Code)

Registrant’s telephone number, including area code: (410) 290-5390

N/A

(Former name or former address, if changed since last report)

 


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

x Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.135-4(c))

 



Item 8.01. Other Events.

As previously disclosed, on May 11, 2007, Celsion Corporation (the “Company”) held a conference call at 11:00 a.m., Eastern Time, to discuss the First Quarter 2007 Results and stockholder questions related to the proposed sale of the Company’s Prolieve assets to Boston Scientific Corporation and certain other proposals to be presented at the 2007 annual meeting of stockholders. A transcript of the conference call is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit
Number
 

Description

99.1   Transcript of Conference Call, dated May 11, 2007


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CELSION CORPORATION
Date: May 15, 2007   By:  

/s/ Anthony P. Deasey

   

Anthony P. Deasey

Chief Financial Officer


EXHIBIT INDEX

 

Exhibit
Number
 

Description

99.1   Transcript of Conference Call, dated May 11, 2007